141 related articles for article (PubMed ID: 15821403)
1. Lower incidence and severity of cytomegalovirus-associated immune recovery uveitis in HIV-infected patients with delayed highly active antiretroviral therapy.
Ortega-Larrocea G; Espinosa E; Reyes-Terán G
AIDS; 2005 Apr; 19(7):735-8. PubMed ID: 15821403
[TBL] [Abstract][Full Text] [Related]
2. Immune-recovery uveitis in patients with cytomegalovirus retinitis taking highly active antiretroviral therapy.
Robinson MR; Reed G; Csaky KG; Polis MA; Whitcup SM
Am J Ophthalmol; 2000 Jul; 130(1):49-56. PubMed ID: 11004259
[TBL] [Abstract][Full Text] [Related]
3. Immune recovery uveitis in AIDS patients with cytomegalovirus retinitis treated with highly active antiretroviral therapy in Venezuela.
Arevalo JF; Mendoza AJ; Ferretti Y
Retina; 2003 Aug; 23(4):495-502. PubMed ID: 12972761
[TBL] [Abstract][Full Text] [Related]
4. Immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis after highly active antiretroviral therapy.
Nguyen QD; Kempen JH; Bolton SG; Dunn JP; Jabs DA
Am J Ophthalmol; 2000 May; 129(5):634-9. PubMed ID: 10844056
[TBL] [Abstract][Full Text] [Related]
5. Immune recovery uveitis.
Kuppermann BD; Holland GN
Am J Ophthalmol; 2000 Jul; 130(1):103-6. PubMed ID: 11004267
[No Abstract] [Full Text] [Related]
6. Effect of anti-cytomegalovirus therapy on the incidence of immune recovery uveitis in AIDS patients with healed cytomegalovirus retinitis.
Song MK; Azen SP; Buley A; Torriani F; Cheng L; Chaidhawangul S; Ozerdem U; Scholz B; Freeman WR
Am J Ophthalmol; 2003 Oct; 136(4):696-702. PubMed ID: 14516810
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
Jabs DA; Van Natta ML; Kempen JH; Reed Pavan P; Lim JI; Murphy RL; Hubbard LD
Am J Ophthalmol; 2002 Jan; 133(1):48-61. PubMed ID: 11755839
[TBL] [Abstract][Full Text] [Related]
8. Immune recovery uveitis.
Dunn JP
Hopkins HIV Rep; 2001 Nov; 13(6):9-10. PubMed ID: 11727417
[No Abstract] [Full Text] [Related]
9. Cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
Whitcup SM
JAMA; 2000 Feb; 283(5):653-7. PubMed ID: 10665706
[TBL] [Abstract][Full Text] [Related]
10. Seven years of HAART impact on ophthalmic management of HIV-infected patients.
Kahraman G; Krepler K; Franz C; Ries E; Maar N; Wedrich A; Rieger A; Dejaco-Ruhswurm I
Ocul Immunol Inflamm; 2005; 13(2-3):213-8. PubMed ID: 16019681
[TBL] [Abstract][Full Text] [Related]
11. Cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
Kedhar SR; Jabs DA
Herpes; 2007 Dec; 14(3):66-71. PubMed ID: 18371289
[TBL] [Abstract][Full Text] [Related]
12. Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.
Whitcup SM; Fortin E; Lindblad AS; Griffiths P; Metcalf JA; Robinson MR; Manischewitz J; Baird B; Perry C; Kidd IM; Vrabec T; Davey RT; Falloon J; Walker RE; Kovacs JA; Lane HC; Nussenblatt RB; Smith J; Masur H; Polis MA
JAMA; 1999 Nov; 282(17):1633-7. PubMed ID: 10553789
[TBL] [Abstract][Full Text] [Related]
13. Discontinuation of maintenance therapy for cytomegalovirus retinitis in HIV-infected patients receiving highly active antiretroviral therapy.
Jouan M; Savès M; Tubiana R; Carcelain G; Cassoux N; Aubron-Olivier C; Fillet AM; Nciri M; Sénéchal B; Chêne G; Tural C; Lasry S; Autran B; Katlama C;
AIDS; 2001 Jan; 15(1):23-31. PubMed ID: 11192865
[TBL] [Abstract][Full Text] [Related]
14. Characterization of reactivation of cytomegalovirus retinitis in patients healed after treatment with highly active antiretroviral therapy.
Song MK; Karavellas MP; MacDonald JC; Plummer DJ; Freeman WR
Retina; 2000; 20(2):151-5. PubMed ID: 10783947
[TBL] [Abstract][Full Text] [Related]
15. Cytomegalovirus retinitis in HIV-infected patients with and without highly active antiretroviral therapy.
Doan S; Cochereau I; Guvenisik N; Diraison MC; Mousalatti H; Thanh HX
Am J Ophthalmol; 1999 Aug; 128(2):250-1. PubMed ID: 10458193
[TBL] [Abstract][Full Text] [Related]
16. Risk of immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis.
Kempen JH; Min YI; Freeman WR; Holland GN; Friedberg DN; Dieterich DT; Jabs DA;
Ophthalmology; 2006 Apr; 113(4):684-94. PubMed ID: 16581429
[TBL] [Abstract][Full Text] [Related]
17. The safety of discontinuation of maintenance therapy for cytomegalovirus (CMV) retinitis and incidence of immune recovery uveitis following potent antiretroviral therapy.
Wohl DA; Kendall MA; Owens S; Holland G; Nokta M; Spector SA; Schrier R; Fiscus S; Davis M; Jacobson MA; Currier JS; Squires K; Alston-Smith B; Andersen J; Freeman WR; Higgins M; Torriani FJ;
HIV Clin Trials; 2005; 6(3):136-46. PubMed ID: 16192248
[TBL] [Abstract][Full Text] [Related]
18. A new acronym, a new threat: IRU.
Proj Inf Perspect; 1999 Sep; (28):11. PubMed ID: 11367354
[TBL] [Abstract][Full Text] [Related]
19. Transient vitreous inflammatory reactions associated with combination antiretroviral therapy in patients with AIDS and cytomegalovirus retinitis.
Zegans ME; Walton RC; Holland GN; O'Donnell JJ; Jacobson MA; Margolis TP
Am J Ophthalmol; 1998 Mar; 125(3):292-300. PubMed ID: 9512145
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000).
Holland GN; Vaudaux JD; Shiramizu KM; Yu F; Goldenberg DT; Gupta A; Carlson M; Read RW; Novack RD; Kuppermann BD;
Am J Ophthalmol; 2008 Jan; 145(1):12-22. PubMed ID: 18154751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
